Skip to main content

The Magic Multibagger | 2 great ‘safety’ stocks for dividend investors

2 great ‘safety’ stocks for dividend investors
Dividends make an enormous difference to investment returns, especially if they are reinvested in more shares — in fact, they can easily turn a good return into a multibagger one. But a big dividend today is no good if it’s unsustainable in the long term and likely to be cut back in the future.

Today I’m looking at two that I think should provide steady streams of income for many years, from two very different sectors.
Motoring success

Dividend safety is one of my key requirements, and I reckon there’s a reliable one to be had from car dealer Pendragon (LSE: PDG). The firm, which sells new and second hand vehicles, and offers repair services, has seen its share price going through a tough patch over the past couple of years, and it took a dive as a result of 2016’s Brexit referendum result — a dip from which it hasn’t fully recovered, though many others have.
Today, at 32.75p, the shares are trading on a forward P/E of only around 8.3, and for 2018 it would drop as low as 7.7 — only around half the long-term rating for the FTSE All-share index. That would be understandable for a company that’s struggling — but Pendragon isn’t.
In fact, 2016 showed a 5.4% rise in underlying earnings per share, and though it’s predicted to remain flat this year, we have 7% growth in EPS pencilled-in for 2018. And chief executive Trevor Finn told us: “We believe that we can achieve at least double-digit growth in used revenue in 2017 and our aspiration over the next five years is to double our used vehicle revenue.“
And the dividend? It was hiked by 11% in 2016, and the company is pursuing a £20m share buyback programme and a “progressive dividend policy“. The forecast yield for 2017 stands at 4.5%, rising to 4.9% in 2018, with cover by earnings of an impressive 2.5 times.
To me that looks like a cheap share, and a strong and safe dividend.
A cheap fund manager
Switching to my second choice, I can’t help thinking Jupiter Fund Management (LSE: JUP) has been performing very well in recent years. It’s certainly ahead of some of its peers, like Aberdeen Asset Management, which has suffered from three years of declining earnings due to its emerging markets focus.
Over the past five years, despite market turmoil, Jupiter has been growing its earnings nicely, and City analysts are expecting that to continue this year and next — and they’re predicting tasty dividend yields of better than 6%.
Admittedly, underlying earnings per share rose by only 1% and net inflows in 2016 slumped by 90% to £1bn in a “challenging” year. But chief executive Maarten Slendebroek reckoned that was “a good result in a year when many active managers suffered net outflows,” and I agree. We also saw assets under management rise in value by 13%, and the firm was able to increase its net management fees by 10%.
Importantly, shareholders enjoyed a 7% rise in total dividends, to 27.2p, and forecasts suggest steady rises for this year and next too — to yield 6.2% in 2017 and 6.5% in 2018.
I reckon Jupiter’s overall performance, both last year and over an impressive track record, should attract cash in the coming years, and I see inflow growth rebounding. And that should help secure those big dividends.
Do you want to be a millionaire?

The Magic Multibagger

Here we are going to share Top 10 Stocks with you according to a strategy  which is endorsed by Warren Buffet, written in “the little book that beats the Market” by Joel Greenblatt. Joel Greenblatt runs a hedge fund named Gotham Capital and has compounded capital at 40% for 20 years from 1985 to 2006.


Know more at: Value Pick


Popular posts from this blog

Sensex Fall More Than a 100 Factors, Under Nifty 9950, Pressure on Pharma Stocks

The fall in the stock marketcontinues to this present day. On Tuesday, after the closure with the autumn, the market began on Wednesday with the decline and fall.The Sensex has misplaced greater than a hundred factors in the initial business. The Nifty reached under 9950 at the moment Sensex 31903 and Nifty fell one hundred ten points to alternate at 9,945, down 33 points. these days many of the drive is being considered on pharma sector.
Sharp Fall in Small Shares..
In today's business small shares are seeing a sharp decline. The smallcap index is set 1 percent down. The mid-sector sector index is down 0.9 percent. within the midcap index, Berger Paints has 4 per cent, Tata chemicals 3.6 per cent, GMR Infra is buying and selling 3.7 per cent down. in the smallcap index, RSW 10%, HDIL 8.6%, Gammon Infra dropped 7%. Pharma Stocks Crash, Metallic Continues to Upward Thrust.
In the Trading of the pharma sector, the largest decline in stocks is viewed on Wednesday. The Pharma Sector In…

Nifty likely to close above 10,000 in July series; 5 stocks which can give up to 14% return

There has been aggressive put writing in near strikes with 9900 strike holds the maximum put open interest indicating strong support zone. The Nifty is moving up and has been making new highs on regular basis with a decent addition in open interest (OI) which indicates the strength in the current trend. The Option writers were active last week as we have seen Put writing in 9900, 9800, 9700 strikes and unwinding in calls. The foreign institutional investors (FII’s) options data also indicates fresh buying in index calls (9900, 10000 strikes). Moreover, from derivative data, it is quite possible that Nifty may expire above 10,000 levels in the current series. As in the recent past, we have seen aggressive put writing in near strikes with 9900 strike holds the maximum put open interest indicating strong support zone. On Tuesday, Call writers were unwinding call short position which once again indicates the possibility of upside before expiry. On the technical front, 9920-9930 spot leve…

SBI Life gets ready for a big IPO this year, may raise Rs 8500-9000 cr

Once listed, this would be the second life insurer after ICICI Prudential Life Insurance to be listed on the stock exchanges.

SBI Life Insurance, which has filed the draft red herring prospectus (DRHP) with Securities and Exchange Board of India (Sebi), is likely to bring out the largest initial public offering (IPO) in the insurance space. Sources said that the insurer could raise as much as Rs 8500-9000 crore from the IPO.

Once listed, this would be the second life insurer after ICICI Pre
dential Life Insurance to be listed on the stock exchanges.

This includes an initial public offer of up to 120 million equity shares of face value of Rs 10 each through an offer for sale by State Bank of India and BNP Paribas Cardif where each will be selling up to 80 million equity shares and up to 40 million equity shares, respectively.

Further, it also includes a reservation of up to 2 million equity shares (constituting up to 0.2 percent of the post-offer paid-up share capital) for purchase by …